外体细胞在肺癌中的治疗潜力
Hongyuan Liang1, Lingyun Zhang2, Xiangxuan Zhao3
1Department of Radiology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Shenyang, 110004, China.
Cellular oncology (Dordrecht, Netherlands)
|June 26, 2023
概括
外体,纳米细胞外囊泡,显示出治疗晚期肺癌 (LC) 的前景. 这些囊泡可以被设计为治疗载体,以抑制瘤生长并提高治疗灵敏度.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 细胞生物学 细胞生物学
背景情况:
- 肺癌 (LC) 是全球领先的恶性瘤,晚期的治疗选择有限.
- 外体,纳米细胞外囊泡,在细胞间通信中至关重要,并与LC进展有关.
- 外体可以影响LC细胞的存活,增殖,迁移,入侵和转移.
研究的目的:
- 审查外体在肺癌治疗中的治疗潜力.
- 阐明LC中外体介导作用背后的分子机制.
- 探索外体作为先进的LC治疗的潜在药物输送载体.
主要方法:
- 关于外体和肺癌的基础和临床研究的综合文献综述.
- 在瘤微环境 (TME) 中对外体组合和功能的分析.
- 基于外体的治疗策略对LC抑制和治疗增强的评估.
主要成果:
- 外体在LC中扮演着双重的角色,促进瘤的进展,并提供治疗机会.
- 细胞利用外体进行细胞间通信,影响TME和转移.
- 外体可以被设计为抑制LC细胞增殖,诱导细胞亡,并提高治疗灵敏度.
结论:
- 外体细胞因其稳定性,特异性和低免疫性而代表了高级肺癌治疗的有希望的平台.
- 了解外体介导的分子机制是开发有效的外体基LC治疗的关键.
- 外基因组在TME中促进细胞间交叉通话,调节LC细胞行为,包括生存,增殖,迁移,入侵,EMT,转移和亡抵抗.
相关概念视频
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


